HBI Deals+Insights / Interviews
Germany’s medical cannabis market has been booming since it was removed from the list of controlled narcotic substances in 2024, which made prescribing it much easier. Now as many as one million Germans are being prescribed cannabis, according to the most often cited figure by those in the industry. The majority of these prescriptions are being handed out by digital health companies specialising in cannabis. The largest of these companies is Bloomwell, who HBI sat down with last week at Cannabis Europa (a conference focused on medicinal cannabis).





